This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| PERSIMMON PLC | 2,175.0 | 5.2% |
| KINGFISHER PLC | 208.9 | 3.6% |
| SMURFIT KAPPA GROUP PLC | 2,452.0 | 3.6% |
| 3I GROUP PLC | 1,184.5 | 3.4% |
| NEXT PLC | 6,216.0 | 3.1% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| FRESNILLO PLC | 703.0 | -3.7% |
| POLYMETAL INTERNATIONAL PLC | 1148.0 | -2.5% |
| IMPERIAL BRANDS PLC | 1774.6 | -1.3% |
| ADMIRAL GROUP PLC | 2084.0 | -0.8% |
| PEARSON PLC | 734.4 | -0.8% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 7,426 | 1.0% | -1.6% |
| DOW JONES INDUS. AVG | 26,820 | -0.3% | 1.7% |
| DAX INDEX | 12,381 | 0.8% | -0.4% |
| NIKKEI 225 | 21,879 | -0.8% | -8.1% |
| S&P/ASX 200 INDEX | 6,716 | 0.6% | 8.7% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 55.85 | -0.11% |
| Brent Crude (ICE) | USD/bbl. | 61.71 | -0.32% |
| Gold Spot | USD/t oz. | 1,490 | -0.5% |
| Copper (Comex) | USd/lb. | 261 | 0.6% |
Click graph to enlarge
UK Index called to open -5 Points at 7422 this morning; Chinese data overnight expanded at its fastest pace for 19 months, however China edged lower overnight ahead of a long holiday, as sentiment was dented by the US considering to delist Chinese companies from US stock exchanges. Oil is flat over the weekend and Gold -0.5% heading into the new week.
AstraZeneca has announced that its drug Tagrisso is the only 1st-line treatment for EGFR-mutated non-small cell lung cancer to deliver a median overall survival of more than three years
Ferrexpo rejects claims that it’s CEO Kostyantin Zhevago has been served with a notice of suspicion regarding an investigation in Ukraine relating to one of the businesses he owned until 2015.
GSK presents new data showing promising anti-tumour activity with GSK3359609, an ICOS receptor agonist, in combination with pembrolizumab in head and neck squamous cell carcinoma.
GSK also announced Phase 3 PRIMA trial of Zejula (niraparib) is the first study to show a PARP inhibitor significantly improves PFS, regardless of biomarker status, when given as monotherapy in women with first-line platinum responsive advanced ovarian cancer.
IQE announces the successful device and module qualification for VCSEL epi-wafers for a major Asian OEM.
Source: Bloomberg, FT, Reuters, DJ Newswires, AlphaTerminal
Pennon Group Upgraded to a buy by Deutsche Bank (Bloomberg: 7 Buys / 4 Holds / 2 Sells)
Whitbread Downgraded to Equal Weight by Barclays (Bloomberg: 3 Buys / 15 Holds / 8 Sells)
Chinese Caixin Manufacturing PMI
UK GDP Q2 QoQ
German Consumer Price Index
GlaxoSmithKline
Greggs, Ferguson
Tesco, Wizz Air, Ted Baker
(Full list available on Week in advance)
DS Smith - 3.2%
Taylor Wimpey - 2.4%
WPP - 2.3%
British American Tobacco - 1.8%
Hays - 5.6%
(Full list available on Week in advance)
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.